Filter Results:
(15,744)
Show Results For
- All HBS Web
(15,744)
- People (54)
- News (3,633)
- Research (9,539)
- Events (86)
- Multimedia (112)
- Faculty Publications (6,918)
Show Results For
- All HBS Web
(15,744)
- People (54)
- News (3,633)
- Research (9,539)
- Events (86)
- Multimedia (112)
- Faculty Publications (6,918)
- Article
Creating Value in the Age of Distributed Capitalism
By: Shoshana Zuboff
Capitalism is a book of many chapters—and we are beginning a new one. Every century or so, fundamental changes in the nature of consumption create new demand patterns that existing enterprises can't meet. When a majority of people want things that remain priced at a... View Details
Zuboff, Shoshana. "Creating Value in the Age of Distributed Capitalism." McKinsey Quarterly, no. 4 (2010): 45–55.
- November 2023
- Case
Axie Infinity: Video Game Meets Blockchain
By: Marco Di Maggio and Wenyao Sha
The narrative unfolds from the perspective of Sky Mavis's leadership team, facing a high-stakes, rapidly evolving digital frontier. They navigate the exhilarating yet tumultuous journey of Axie Infinity, balancing innovation with sustainability. It explores the game's... View Details
Keywords: Blockchain; Business Model; Games, Gaming, and Gambling; Currency; Innovation and Management; Business Strategy; Video Game Industry
Di Maggio, Marco, and Wenyao Sha. "Axie Infinity: Video Game Meets Blockchain." Harvard Business School Case 224-021, November 2023.
- 2015
- Chapter
Innovation and Business Growth
By: William R. Kerr
Innovation and the pursuit of new business opportunities are essential for growth at the firm level; moreover, they provide the foundation for an economy to achieve new levels of technological prowess, productivity, and ultimately prosperity. This chapter describes... View Details
Kerr, William R. "Innovation and Business Growth." In Designing the Future: Economic, Societal and Political Dimensions of Innovation, edited by Austrian Council for Research and Training Development, 137–156. Vienna, Austria: Echomedia Buchverlag, 2015.
- Article
Act Like a Scientist: Great Leaders Challenge Assumptions, Run Experiments, and Follow the Evidence
By: Stefan Thomke and Gary W. Loveman
Though they’ve been warned for decades about the dangers of overrelying on gut instinct and personal experience, managers keep failing to critically examine—much less challenge—the ideas their decisions are based on. To correct this problem they need to think and act... View Details
Thomke, Stefan, and Gary W. Loveman. "Act Like a Scientist: Great Leaders Challenge Assumptions, Run Experiments, and Follow the Evidence." Harvard Business Review 100, no. 3 (May–June 2022): 120–129.
- October 1988 (Revised June 1993)
- Case
Siemens Electric Motor Works (A): Process-Oriented Costing
Explores how a cost system can help support a firm's decision to change strategies. In the process, the students are introduced to a simple activity-based cost system. Siemens Electric Motor Works found itself facing an increasingly competitive environment and so made... View Details
Cooper, Robin, and Karen Wruck. "Siemens Electric Motor Works (A): Process-Oriented Costing." Harvard Business School Case 189-089, October 1988. (Revised June 1993.)
- January 2009
- Supplement
Yieldex (B)
Yieldex CEO Tom Shields was hired by the company's technical founder, Doug Cosman, in October 2007. One of Shields' top priorities is finding a vice president of engineering to manage the company's software development efforts. Shields and Costman disagree about the... View Details
Keywords: Selection and Staffing; Applications and Software; Engineering; Decision Choices and Conditions; Product Development; Information Technology Industry
Stuart, Toby E., and Alison Berkley Wagonfeld. "Yieldex (B)." Harvard Business School Supplement 809-091, January 2009.
- September 1974 (Revised July 1979)
- Background Note
A Note on Process Analysis
By: Paul W. Marshall
Provides an introductory note to production processes and the use of flow diagram. View Details
Marshall, Paul W. "A Note on Process Analysis." Harvard Business School Background Note 675-038, September 1974. (Revised July 1979.)
- May 2024
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting... View Details
Keywords: Health Care and Treatment; Technological Innovation; Product Development; Health Testing and Trials; Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics 115, no. 5 (May 2024): 988–992.
- October 2008
- Article
The Small World of Investing: Board Connections and Mutual Fund Returns
By: Lauren Cohen, Andrea Frazzini and Christopher J. Malloy
This paper uses social networks to identify information transfer in security markets. We focus on connections between mutual fund managers and corporate board members via shared education networks. We find that portfolio managers place larger bets on firms they are... View Details
Keywords: Financial Markets; Information Management; Social and Collaborative Networks; Announcements; Investment Portfolio; Investment Return; Investment Funds; Asset Pricing; Governing and Advisory Boards
Cohen, Lauren, Andrea Frazzini, and Christopher J. Malloy. "The Small World of Investing: Board Connections and Mutual Fund Returns." Journal of Political Economy 116, no. 5 (October 2008): 951–979. (Winner of the Barclays Global Investors Award, Best Paper in Asset Pricing, European Finance Association 2007.)
- February 2022
- Case
Toraya
By: Lauren Cohen and Akiko Kanno
Mitsuharu Kurokawa was the 18th generation leader of a family firm that produced and sold premium Japanese sweets, Toraya Confectionery Co., Ltd. He had succeeded the business from his father, Mitsuhiro Kurokawa who had led the firm for thirty years. Mitsuharu was... View Details
- 2021
- Working Paper
Quantifying the Value of Iterative Experimentation
By: Iavor I Bojinov and Jialiang Mao
Over the past decade, most technology companies and a growing number of conventional firms have adopted online experimentation (or A/B testing) into their product development process. Initially, A/B testing was deployed as a static procedure in which an experiment was... View Details
Bojinov, Iavor I., and Jialiang Mao. "Quantifying the Value of Iterative Experimentation." Harvard Business School Working Paper, No. 24-059, March 2024.
- 07 Nov 2006
- First Look
First Look: November 7, 2006
management and production techniques, and global integration that spurred the "New Economy" of the 1990s had triggered profound and lasting changes. Frontiers of Capital brings together... View Details
Keywords: Sean Silverthorne
- 29 Nov 2016
- Working Paper Summaries
Fiscal Risk and the Portfolio of Government Programs
- 2020
- Working Paper
Private Equity and COVID-19
By: Paul A. Gompers, Steven N. Kaplan and Vladimir Mukharlyamov
We survey more than 200 private equity (PE) managers from firms with $1.9 trillion of assets under management (AUM) about their portfolio performance, decisionmaking and activities during the Covid-19 pandemic. Given that PE managers have significant incentives to... View Details
Keywords: Health Pandemics; Private Equity; Management; Investment Portfolio; Performance; Decision Making; Value Creation
Gompers, Paul A., Steven N. Kaplan, and Vladimir Mukharlyamov. "Private Equity and COVID-19." NBER Working Paper Series, No. 27889, October 2020.
- 04 Oct 2019
- HBS Seminar
Annabelle Fowler (Harvard University), Harvard University
- 24 Aug 2015
- Working Paper Summaries
Multi-Product Duopoly with Cross-Product Cost Interdependencies
- January 2018 (Revised January 2019)
- Case
ZappRx
By: Jeffrey J. Bussgang and Olivia Hull
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
- 28 Apr 2015
- First Look
First Look: April 28
principles, and skills of three of the most successful and influential figures in business-Bill Gates, Andy Grove, and Steve Jobs-offering lessons for all managers and entrepreneurs on leadership, strategy, and execution. In less than a... View Details
Keywords: Sean Silverthorne
- July 2013 (Revised March 2015)
- Case
Carl Zeiss and Free-Form Production: Can We See Clearly Yet?
By: Willy Shih
The prescription eyeglass lens industry was complicated and highly fragmented, and even though many of the tools and techniques employed have been relatively unchanged over the last century, there was still a surprising pace of innovation. An aging population around... View Details
Keywords: History; Demand and Consumers; Disruptive Innovation; Vertical Integration; Theory; Technology Adoption; Health Industry
Shih, Willy. "Carl Zeiss and Free-Form Production: Can We See Clearly Yet?" Harvard Business School Case 614-007, July 2013. (Revised March 2015.)
- September 2003 (Revised March 2007)
- Case
Direvo Biotech AG
Describes the financing and growth decisions facing Direvo, a young German biotech firm with a customer/partner that wants to become an investor. Also discusses the business model for Direvo's directed evolution technology, with applications in both industrial enzymes... View Details
Keywords: Business Model; Decisions; Business Exit or Shutdown; Value; Business Startups; Biotechnology Industry; Germany
Roberts, Michael J., Vincent Dessain, and Anders Sjoman. "Direvo Biotech AG." Harvard Business School Case 804-017, September 2003. (Revised March 2007.)